Location: Home
  • search
  • go
  • Relate News
  • 12/17/2025CDE Solicits Comments on Draft Guidelines for Generic Ophthalmic Eye ...
  • 12/17/2025China Launches Pilot Program for Classified Management of Imported Foo...
  • 12/17/2025China's New Drug Commercial Insurance Scheme Offers Hope for Patients ...
  • 12/17/2025Understanding China's Pharmaceuticals Patent Linkage System: Judicial ...
  • 12/17/2025Understanding China's Pharmaceutical Patent Linkage System: Framework ...
  • 12/16/2025InnoCare's Orelabrutinib Hits Primary Endpoint in Phase 2b Lupus Trial...
  • 12/16/2025Western Gene Therapy Developers Look to China for Faster, Lower-Cost C...
  • 12/16/2025Fosun Moves to Acquire Maker of Controversial Alzheimer's Drug
  • 12/16/2025China Approves Genzyme's Fenthosilan Sodium Injection
  • 12/16/2025D3 Bio Raises $108M Series B to Advance Global Phase III Program for ...
  • 12/16/2025GeneScience Signs Up to $1.37B Global Licensing Deal for TSHR Antibody...
  • 12/15/2025NHSA Unveils Three-Year Plan to Accelerate BMI Fund Clearing and Settl...
  • 12/15/2025BroadenBio Raises ~CNY 100M in Series A+ to Advance Oncology and Autoi...
  • 12/15/2025Everest Signs Dual Strategic Deals With Hasten to Expand Commercial Re...
  • 12/15/2025Insilico Licenses AI-Designed Anemia Drug ISM4808 to TaiGen for Greate...
  • 12/15/2025Sino Biopharm Wins NMPA Approval for FIC Triple CDK Inhibitor in Breas...
  • 12/15/2025InnoCare Secures NMPA Approval for Pan-TRK Inhibitor Zurletrectinib
  • 12/15/2025Qilu Wins Approval for China's First Fully Human Anti-EGFR Antibody
  • 12/15/2025AusperBio Reports Promising Phase 2a Results for AHB-137 in Chronic He...
  • 12/15/2025Qilu Advances GSPT1 Degrader ADC Program, PCT Patent Reveals
  • 12/15/2025KYinno Raises ~CNY 250M in Series B to Advance Multispecific Antibod...
  • 12/15/2025CDE Seeks Comments on Draft Technical Guidelines for Generic Ophthalmi...
  • 12/15/2025CDE Solicits Comments on First Batch of ICH M13A Low-Risk Formulation ...
  • 12/12/2025InnoCare Pharma Wins NMPA Approval for Next-Gen TRK Inhibitor Zurletre...
  • 12/12/2025Ascletis' Acne Drug Denifanstat Enters NMPA Review After NDA Acceptanc...
  • 12/12/2025CMS's NDA for Innovative Stroke Drug Y-3 for Injection Accepted in Ch...
  • 12/12/2025Abraham Accords Partners Could Help the U.S. Reduce Pharma Dependence ...
  • 12/12/2025Sidera Secures $109M in Major Series A and Global Rights to China-Orig...
  • 12/12/2025Recent Executive Moves
  • 12/11/2025Formation Bio Secures Global Rights to Lynk Pharma's CNS-Targeted TYK2...
  • Page:10/814 Total number of articles:24415: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group